EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Possible Role of Β-Cell Senescence in the Development of Type 2 Diabetes Mellitus

Elena G Novoselova, Sergey M Lunin, Maxim O Khrenov, Olga V Glushkova, Tatiana V Novoselova, Svetlana B Parfenyuk

Cellular Physiology and Biochemistry · 15.02.2023 · 57 (1) · 34-48

DOI: 10.33594/000000606 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Physiology and Biochemistry, online erschienen am 15.02.2023. Verfasst von Elena G Novoselova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cell Biophysics, Russian Academy of Sciences, PSCBR RAS, Pushchino, Moscow, Russia , elenanov_06@mail.ru. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Ferroptosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Gefördert von: Russian Scientific Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This minireview discusses the very important biomedical problem of treating type 2 diabetes mellitus (T2D). T2D accounts for more than 90% of the total number of diagnosed cases of diabetes mellitus and can result from aging, inflammation, obesity and β-cell senescence. The main symptom of both T2D and type 1 diabetes (T1D) is an increase in blood glucose concentration. While T1D is insulin-dependent and is associated with the destruction of pancreatic β-cells, T2D does not require lifelong insulin administration. In this case, pancreatic β-cells are not destroyed, but their functional activity is deregulated. In T2D, metabolic stress increases the number of senescent β-cells while impairing glucose tolerance. The potential paracrine effects of senescent β-cells highlight the importance of the β-cell senescence- associated secretory phenotype (SASP) in driving metabolic dysfunction. We believe that the main reason for the deregulation of the functional activity of pancreatic β-cells in T2D is associated with their “aging” or senescence, which may be induced by various stressors. We propose the use of peroxiredoxin 6 as a new senolytic drug, and the role of β-cell senescence in the development of T2D is discussed in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1FerroptosisHumansIronInsulinFatty Acids, UnsaturatedDietary Supplements

Stichwörter der Autor:innen

Type 2 diabetes mellitus ; Senescent β-cells ; Aging ; Inflammation ; Obesity

Substanzen

IronInsulinFatty Acids, Unsaturated

Autor:innen und Institutionen

  • Institute of Cell Biophysics, Russian Academy of Sciences, PSCBR RAS, Pushchino, Moscow, Russia , elenanov_06@mail.ru.
  • Institute of Cell Biophysics, Russian Academy of Sciences, PSCBR RAS, Pushchino, Moscow, Russia.

Förderung

  • Russian Scientific Foundation

Zitieren

APA

Novoselova, E. G., Lunin, S. M., Khrenov, M. O., Glushkova, O. V., Novoselova, T. V., & Parfenyuk, S. B. (2023). The Possible Role of Β-Cell Senescence in the Development of Type 2 Diabetes Mellitus. Cellular Physiology and Biochemistry, 57(1), 34-48. https://doi.org/10.33594/000000606

Vancouver

Novoselova EG, Lunin SM, Khrenov MO, Glushkova OV, Novoselova TV, Parfenyuk SB. The Possible Role of Β-Cell Senescence in the Development of Type 2 Diabetes Mellitus. Cellular Physiology and Biochemistry. 2023;57(1):34-48. doi:10.33594/000000606

BibTeX
@article{Novoselova2023,
  author = {Novoselova, Elena G and Lunin, Sergey M and Khrenov, Maxim O and Glushkova, Olga V and Novoselova, Tatiana V and Parfenyuk, Svetlana B},
  title = {The Possible Role of Β-Cell Senescence in the Development of Type 2 Diabetes Mellitus},
  journal = {Cellular Physiology and Biochemistry},
  year = {2023},
  volume = {57},
  number = {1},
  pages = {34--48},
  doi = {10.33594/000000606}
}
Kostenlos starten →